ANI Pharmaceuticals
Baudette, MNDevelopment, manufacture, and marketing of branded and generic prescription pharmaceuticals
View Company
The specialty products sector comprises companies developing, manufacturing, and commercializing highly specialized medical products.
Within this space, Ampersand has focused on investing in and supporting companies for whom industrialization strategies will create value. Our commitment to building industry leaders extends to guiding companies as they navigate the competitive landscape and evolving regulatory requirements.
Ampersand collaborates with portfolio companies to identify growth opportunities and overcome operational, strategic, and financial challenges. This multifaceted approach helps to position our portfolio companies as desirable partners, drives long-term value creation, and fosters their emergence as industry leaders in the specialty products sector.
Development, manufacture, and marketing of branded and generic prescription pharmaceuticals
View Company
Global leader of innovations for clinically efficacious active healing and surgical orthobiologics
IPO in June 2024 (Nasdaq: BVS)
View Company
Global manufacturer of high-performance plastic packaging for the pharmaceutical, specialty chemicals, and logistics industries.
View Company
Development and commercialization of value-added medical kits for compounding pharma
Acquired by NovaQuest in 2016
View Company
CDMO specializing in the development, scaling, and manufacturing of polyethylene glycol (PEG) reagents
View Company
Collection and fractionation of blood plasma for the production of plasma-derived therapies
View Company
Lexington Medical designs and manufactures high-performance endoscopic stapling devices, which are proudly made in the USA and used in a wide range of surgical procedures.
View Company
Leading compounding pharmacy focused on the companion animal market
Acquired by Vets First Choice in 2017
View Company